# FDA recall D-0568-2022

> **ANI Pharmaceuticals, Inc.** · Class II · drug recall initiated 2022-02-15.

## Product

Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.

## Reason for recall

cGMP Deviations

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0568-2022
- **Recalling firm:** ANI Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-02-15
- **Report date:** 2022-02-23
- **Termination date:** 2022-10-25

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baudette, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0568-2022

## Citation

> AI Analytics. FDA recall D-0568-2022. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0568-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*